Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18642657 | 0.83 | GAA (0.33) | KMT2AP2RX7HDAC3HDAC1HDAC2 | |
| SCHEMBL19697636 | 0.76 | P2RX7 (0.46) | P2RX7CYP3A4 | |
| SCHEMBL19697613 | 0.73 | P2RX7 (0.41) | P2RX7HDAC3HDAC1HDAC2HDAC6 | |
| SCHEMBL26045507 | 0.72 | P2RX7 (0.33) | P2RX7HDAC3HDAC1HDAC2HDAC6 | |
| SCHEMBL18639384 | 0.72 | SMN1; SMN2 (0.50) | KMT2AGAASMN1; SMN2 | |
| SCHEMBL25957148 | 0.69 | MMP1 (0.33) | — | |
| SCHEMBL27434635 | 0.69 | GRIN2D (0.31) | KMT2A | |
| SCHEMBL21400696 | 0.68 | MAOA (0.33) | KMT2ASMN1; SMN2 | |
| SCHEMBL26190694 | 0.66 | — | — | |
| SCHEMBL27432203 | 0.65 | MTNR1A (0.35) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023158769-A1 | PROCESSES FOR THE PREPARATION OF N-(1- METHYLCYCLOPROPYL)-2-(3 -PYRIDINYL)-2H- INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF | FMC CORPORATION (US) | 2023-08-24 | — | — | WO | disclosed |